B. Combe, Polyarthrite rhumatoïde de l'adulte, épidémiologie, clinique et diagnostic. DIU Etude approfondie des polyarthrites et maladies systémiques, 2016.

B. Combe, Early rheumatoid arthritis: strategies for prevention and management, Best Pract Res Clin Rheumatol, vol.21, issue.1, pp.27-42, 2007.

F. Guillemin and A. Saraux, Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, vol.64, issue.10, pp.1427-1457, 2001.

J. Morel and A. Saraux, Immunopathologie de la polyarthrite rhumatoïde, DIU Etude approfondie des polyarthrites et maladies systémiques. 2016. cours n°3

D. Aletaha and T. Neogi, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative, Ann Rheum Dis, vol.69, issue.9, pp.1580-1588, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01557559

J. Jantti and K. Aho, Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study, Rheumatology (Oxford), vol.38, issue.11, pp.1138-1179, 1999.

B. Combe and A. Cantagrel, Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis, J Rheumatol, vol.30, issue.11, pp.2344-2353, 2003.

M. Korpela and L. Laasonen, Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study, Arthritis Rheum, vol.50, issue.7, pp.2072-81, 2004.

B. Combe and R. Landewe, EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, vol.66, issue.1, pp.34-45, 2007.

D. T. Felson and J. S. Smolen, American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials, Arthritis Rheum, vol.63, issue.3, pp.573-86, 2011.

A. L. Van-gestel and M. L. Prevoo, Development and validation of the European League against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League against Rheumatism Criteria, Arthritis Rheum, vol.39, issue.1, pp.34-40, 1996.

B. Combe and R. Landewe, EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, vol.66, issue.1, pp.34-45, 2007.

R. L. Kolotkin, K. Meter, and G. R. Williams, Quality of life and obesity, Obes Rev, vol.2, pp.2-19, 2001.

E. E. Calle, M. J. Thum, J. M. Petrelli, C. Rodriguez, and C. W. Heath, Body mass index and mortality in a prospective cohort of US adults, N Engl J, vol.341, pp.1097-105, 1999.

K. F. Adams, A. Schatzkin, T. B. Harris, V. Kipnis, T. Mouw et al., Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med, vol.355, pp.763-78, 2006.

, Overweight / Obesity: Overweight (body mass index >25) by country. World Health Organisation -Global Health Observatory Data Repository, 2016.

A. Stavropoulos--kalinoglou, G. Metsios, Y. Koutedakis, and G. Kitas, Obesity in rheumatoid arthritis, Rheumatology (Oxford), vol.50, pp.450-62, 2011.

A. Finckh and C. Turesson, The impact of obesity on the developpement and progression of rheumatoid arthritis, Ann Rheum Dis, vol.73, pp.1911-1913, 2014.

A. Naranjo, T. Sokka, M. Descalzo, J. Calvo--alen, K. Horslev--petersen et al., Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST -RA study, Arthritis Res Ther, vol.10, p.30, 2008.

D. Armstrong, E. Mccausland, A. Quinn, and G. Wright, Obesity ans cardiovascular risk factors factors in rheumatoid arthritis, Rheumatology (Oxford), vol.45, p.782, 2006.

B. Lu, L. T. Hiraki, J. A. Sparks, S. Malspeis, C. Y. Chen et al., Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study, Ann Rheum Dis, vol.73, pp.1914-1922, 2014.

S. Ajeganova, M. L. Andersson, and I. Hafstrom, Association of obesity with worse disease severity in rheumatoid arthritis as well as witrh comorbidities: a long-term followup from disease onset, Arthritis Care Res (Hoboken), vol.65, pp.78-87, 2013.

Y. Liu, G. S. Hazelwood, G. G. Kaplan, B. Eksteen, and C. Barnabe, Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis, Arthritis Care Res (Hoboken), vol.69, issue.2, pp.157-165, 2017.

A. H. Van-der-helm--van-mil, S. M. Van-der-kooij, C. F. Allaart, R. E. Toes, and T. W. Huizinga, A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis, Ann Rheum Dis, vol.67, pp.769-74, 2008.

L. Heimans, M. Van-den-broek, and S. Le-cessie, Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients, Arthritis Care Res, vol.65, pp.1235-1277, 2013.

R. Klaasen, C. A. Wijbrandts, and D. M. Gerlag, Body mass index and clinical response to infliximab in rheumatoid arthritis, Arthritis Rheum, vol.63, pp.359-64, 2011.

G. Westhoff, R. Rau, and A. Zink, Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index, Arthritis Rheum, vol.56, pp.3575-82, 2007.

S. S. Dunkelman, B. Fairhurst, and J. Plager, Cortisol metabolism in obesity, J Clin Endocrinol Metab, vol.24, pp.832-873, 1964.

H. Tilg and A. R. Moschen, Adipocytokines: mediators linking adipose tissue, inflammation and immunity, Nat Rev Immunol, vol.6, pp.772-83, 2006.

Y. H. Rho, J. Solus, T. Sokka, A. Oeser, C. P. Chung et al., Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis, Arthritis Rheum, vol.60, pp.1906-1920, 2009.

J. P. Bastard, C. Jardel, and E. Bruckert, Elevated levels of interleukin 6 are reduced in serumand subcutaneous adipose tissue of obese women after weight loss, J Clin Endocrinal Metab, vol.85, pp.3348-3390, 2000.

M. Visser, L. M. Bouter, and G. M. Mc-quillan, Elevated C-reactive protein levels in overweight and obese adults, JAMA, vol.282, pp.2131-2136, 1999.

E. Gremese, A. Carletto, and M. Padovan, Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalized medicine, Arthritis Care Res, vol.65, pp.94-100, 2013.

A. Gardette, S. Ottaviani, J. Sellam, F. Berenbaum, F. Lioté et al., Body mass index and response to abatacept in rheumatoid arthritis, Eur J Clin Invest, vol.46, issue.12, pp.1048-1052, 2016.

A. Gardette, S. Ottaviani, J. Sellam, F. Berenbaum, F. Lioté et al., Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study, Clin Rheumatol, vol.35, pp.857-61, 2016.

D. Hair, M. J. Landewe, R. B. Van-de-sande, and M. G. , Smoking and overweight determine the likelihood of developing rheumatoid arthritis, Ann Rheum Dis, vol.72, pp.1654-1662, 2013.

N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, Adipokines in inflammation and metabolic disease, Nat Rev Immunol, vol.11, pp.85-97, 2011.

U. Muller-ladner and E. Neumann, Rheumatoid arthritis: the multifaceted role of adiponectin in inflammatory joint disease, Nat Rev Rheumatol, vol.5, pp.659-60, 2009.

T. J. Guzik, D. Mangalat, and R. Korbut, Adipocytokines-novel link between inflammation and vascular function?, J Physiol Pharmacol, vol.57, pp.505-533, 2006.

L. Voigt, T. Koepsell, J. Nelson, C. Dugowson, and J. Daling, Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis, Epidemiology, vol.5, pp.525-557, 1994.

D. Symmons, C. Bankhead, B. J. Harrisson, P. Brennan, E. M. Barrett et al., Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results for a primary care-based incident case control study in, Arthritis Rheum, vol.40, pp.1955-61, 1997.

C. Turesson, U. Bergstrom, M. Pikwer, J. A. Nilsson, and L. T. Jacobsson, A high body mass index is associated with reduced risk of rheumatoid arthritis in men, but not in women, Rheumatology (oxford), vol.55, pp.307-314, 2016.

M. Mirpourian, M. Salesi, H. Abdolahi, Z. Farajzadegan, and H. Karimzadeh, The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis, J Res Med Sci, vol.19, pp.509-523, 2014.

A. Stavropoulos--kalinoglou, G. S. Metsios, V. F. Panoulas, A. M. Nevill, A. Z. Jamurtas et al., Underweight and obese states both ascociate with worse disease activity and physical function in patients with established rheumatoid arthritis, Clin Rheumatol, vol.28, pp.439-483, 2009.

A. Garcia-poma, M. I. Segami, C. S. Mora, M. F. Ugarte, H. N. Terrazas et al., Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis, Clin Rheumatol, vol.26, pp.1831-1836, 2007.

M. E. Sandberg, C. Bengtsson, H. Kallberg, A. Wesley, L. Klareskog et al., Overweigt decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis, Ann Rheum Dis, vol.73, pp.2029-2062, 2014.

Y. M. Pers, M. Godfrin-valnet, J. Lambert, C. Fortunet, E. Constant et al., Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient, J Rheumatol, vol.42, pp.580-584, 2015.

J. Smolen, R. Landewe, F. Breedveld, M. Dougados, P. Emery et al., Eular recommandations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Ann Rheum Dis, vol.69, pp.964-75, 2010.

C. Gaujoux-viala, L. Gossec, A. Cantagrel, M. Dougados, B. Fautrel et al., Recommandations de la société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoide, Rev Rhum, vol.81, pp.303-315, 2014.

D. De-rooy, M. Van-der-linden, R. Knevel, and T. Huizinga, Van der Helmvan Mil A. Predicting arthritis outcomes -what can be learned from the Leiden early arthritis clinic ?, Rheumatology (Oxford), vol.50, pp.93-100, 2011.

M. J. Hanley, D. R. Abernethy, and D. J. Greenblatt, Effect of obesity on the pharmacokinetics of drugs in humans, Clin Pharmacokinet, vol.49, pp.71-87, 2010.

F. Iannone, D. Courvoisier, J. E. Gottenberg, M. V. Hernandez, E. Lie et al., Body Mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA, Clin Rheumatol, 2016.

L. Bustamente, V. Breul, R. Fabre, L. Bailly, C. Pradier et al., Evolution de la densité minérale osseuse au cours de la polyarthrite rhumatoide sous biothérapie versus sans biothérapie -Suivi à 8 ans. Publication en cours 54. WHO. Obesity: preventing and managing the global epidemic, Technical Report Series, p.894, 2000.

M. D. Minno, R. Peluso, S. Iervolino, R. Lupoli, A. Russolillo et al., Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis, Arthritis Care Res (Hubocan), vol.65, pp.141-148, 2013.

L. Eder, A. Thavaneswaran, V. Chandran, R. Cook, and D. Gladam, Obesity is associated with en lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis, Ann Rheum Dis, vol.74, pp.813-820, 2015.

S. Ottaviani, Y. Allanore, F. Tubach, M. Forien, A. Gardette et al., Body mass index influences the response to infliximab in ankylosing spondylitis, Arthritis Res Ther, vol.14, p.115, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00704843

E. Gremese, S. Bernardi, S. Bonazza, M. Nowik, G. Peluso et al., Body weight, gender and response to TNF alpha blockers in axial spondyloarthritis, Rheumatology (Oxford), vol.53, pp.875-81, 2014.

F. Ursini, E. Russo, M. L. Hribal, D. Mauro, F. Savarino et al., Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study, Medicine (Baltimore), vol.94, issue.21, p.888, 2015.

M. Fujii, N. Sonoda, R. Takayanagi, and T. Inoguchi, Targeting obesity, insulin resistance and type 2 diabetes with immunotherapy: the challenges ahead, Immunotherapy, vol.6, pp.5-7, 2014.

A. Stavropoulos--kalinoglou, G. Metsios, V. Panoulas, P. Nightingale, Y. Koutedakis et al., Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis, Arthritis Res Ther, vol.14, p.160, 2012.

G. Gallo, G. Candilio, D. Luca, E. Iannicelli, A. Sciaudone et al., Bariatric surgery and Rheumatic diseases: a literature review, Rev Recent Clin Trials, 2018.

S. Singh, A. Facciorusso, A. G. Singh, N. V. Casteele, A. Zarrinpar et al., Obesity and response to anti-tumor necrosis factoragents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis, PLoS One, vol.13, issue.5, p.195123, 2018.

N. M. Mostafa, A. M. Nader, P. Noertersheuser, M. Okun, and W. M. Awni, Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis, J Eur Acad Dermatol Venereol, vol.31, issue.3, pp.490-497, 2017.